No. As of October 2026, Racura Oncology Ltd (RAC.AX) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Racura Oncology Ltd does not pass Musaffa's business and financial screening criteria.
Racura Oncology Ltd. is a Phase 3 clinical biopharmaceutical company with a dedicated mission to be at the heart of cancer care. The firm's lead asset, RCDS1 (E,E-bisantrene), is a small molecule anticancer agent that primarily functions via G4-DNA and RNA binding, leading to potent inhibition of the important cancer growth regulator MYC. RCDS1 has demonstrated therapeutic activity in cancer patients with a well characterized safety profile. The firm is advancing a formulation of RCDS1 (RC220) to address the high unmet needs of patients across multiple oncology indications, with Phase III clinical programs in acute myeloid leukemia (AML), a Phase I a/b program in mutant epidermal growth factor receptor non-small cell lung cancer (EGFRm NSCLC), and a Phase I a/b program in combination with the anthracycline doxorubicin, where the Company is focused on delivering both cardioprotection and enhanced anticancer activity for solid tumor patients.
Racura Oncology Ltd RAC.AX
AUD1.77 AUD0.09 (4.84%) 1D
Last Updated: Oct 07, 12:00 AM·ASX
Pricing for AU stocks is delayed by 24 hours
RAC.AX Shariah Compliance
Screening Methodology: AAOIFI
As of October 2026, Racura Oncology Ltd is classified as not halal.
NOT HALAL
Racura Oncology Ltd (RAC.AX) Chart
Fetching Price Chart...
Financial Metrics & Statements of Racura Oncology Ltd (RAC.AX)
FAQ's for Racura Oncology Ltd (RAC.AX)
As of October 2026, Racura Oncology Ltd RAC.AX is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Racura Oncology Ltd using these criteria to determine its compliance status.
Muslim investors may consider investing in Racura Oncology Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Racura Oncology Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Racura Oncology Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Racura Oncology Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Racura Oncology Ltd (RAC.AX)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.